Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
371.8000 -7.80 (-2.05%)
NSE Jan 12, 2026 15:31 PM
Volume: 2.1M
 

logo
Biocon Ltd.
02 Nov 2020
371.80
-2.05%
Axis Direct
Biocon Ltd is an integrated biotechnology enterprise with a presence in biopharmaceuticals, enzymes, custom research and clinical research. The Company's pharmaceutical products include statins, immune suppressants and anti-diabetic drugs.
Biocon Ltd. has an average target of 401.80 from 5 brokers.
More from Biocon Ltd.
Recommended